BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37156797)

  • 1. Lipid flipping in the omega-3 fatty-acid transporter.
    Nguyen C; Lei HT; Lai LTF; Gallenito MJ; Mu X; Matthies D; Gonen T
    Nat Commun; 2023 May; 14(1):2571. PubMed ID: 37156797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.
    Nguyen LN; Ma D; Shui G; Wong P; Cazenave-Gassiot A; Zhang X; Wenk MR; Goh EL; Silver DL
    Nature; 2014 May; 509(7501):503-6. PubMed ID: 24828044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mfsd2a utilizes a flippase mechanism to mediate omega-3 fatty acid lysolipid transport.
    Chua GL; Tan BC; Loke RYJ; He M; Chin CF; Wong BH; Kuk ACY; Ding M; Wenk MR; Guan L; Torta F; Silver DL
    Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2215290120. PubMed ID: 36848557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mfsd2a Is a Transporter for the Essential ω-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development.
    Wong BH; Chan JP; Cazenave-Gassiot A; Poh RW; Foo JC; Galam DL; Ghosh S; Nguyen LN; Barathi VA; Yeo SW; Luu CD; Wenk MR; Silver DL
    J Biol Chem; 2016 May; 291(20):10501-14. PubMed ID: 27008858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain.
    Chan JP; Wong BH; Chin CF; Galam DLA; Foo JC; Wong LC; Ghosh S; Wenk MR; Cazenave-Gassiot A; Silver DL
    PLoS Biol; 2018 Aug; 16(8):e2006443. PubMed ID: 30074985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mfsd2a: A Physiologically Important Lysolipid Transporter in the Brain and Eye.
    Wong BH; Silver DL
    Adv Exp Med Biol; 2020; 1276():223-234. PubMed ID: 32705603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A.
    Quek DQ; Nguyen LN; Fan H; Silver DL
    J Biol Chem; 2016 Apr; 291(18):9383-94. PubMed ID: 26945070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine Fish-Derived Lysophosphatidylcholine: Properties, Extraction, Quantification, and Brain Health Application.
    Ahmmed MK; Hachem M; Ahmmed F; Rashidinejad A; Oz F; Bekhit AA; Carne A; Bekhit AEA
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of Placental Major Facilitator Superfamily Domain Containing 2a in Pregnant Mice Reduces Fetal Brain Growth and Phospholipid Docosahexaenoic Acid Content.
    Powell TL; Barentsen K; Vaughan O; Uhlson C; Zemski Berry K; Erickson K; Faer K; Chassen SS; Jansson T
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome.
    Guemez-Gamboa A; Nguyen LN; Yang H; Zaki MS; Kara M; Ben-Omran T; Akizu N; Rosti RO; Rosti B; Scott E; Schroth J; Copeland B; Vaux KK; Cazenave-Gassiot A; Quek DQ; Wong BH; Tan BC; Wenk MR; Gunel M; Gabriel S; Chi NC; Silver DL; Gleeson JG
    Nat Genet; 2015 Jul; 47(7):809-13. PubMed ID: 26005868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate binding-induced conformational transitions in the omega-3 fatty acid transporter MFSD2A.
    Bergman S; Cater RJ; Plante A; Mancia F; Khelashvili G
    Nat Commun; 2023 Jun; 14(1):3391. PubMed ID: 37296098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of omega-3 fatty acid transport across the blood-brain barrier.
    Cater RJ; Chua GL; Erramilli SK; Keener JE; Choy BC; Tokarz P; Chin CF; Quek DQY; Kloss B; Pepe JG; Parisi G; Wong BH; Clarke OB; Marty MT; Kossiakoff AA; Khelashvili G; Silver DL; Mancia F
    Nature; 2021 Jul; 595(7866):315-319. PubMed ID: 34135507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipid transporter Mfsd2a maintains pulmonary surfactant homeostasis.
    Wong BH; Mei D; Chua GL; Galam DL; Wenk MR; Torta F; Silver DL
    J Biol Chem; 2022 Mar; 298(3):101709. PubMed ID: 35150739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mfsd2a attenuated hypoxic-ischemic brain damage via protection of the blood-brain barrier in mfat-1 transgenic mice.
    Li X; Zhang Y; Chang J; Zhang C; Li L; Dai Y; Yang H; Wang Y
    Cell Mol Life Sci; 2023 Feb; 80(3):71. PubMed ID: 36820986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted Blood-Retina Lysophosphatidylcholine Transport Impairs Photoreceptor Health But Not Visual Signal Transduction.
    Lobanova ES; Schuhmann K; Finkelstein S; Lewis TR; Cady MA; Hao Y; Keuthan C; Ash JD; Burns ME; Shevchenko A; Arshavsky VY
    J Neurosci; 2019 Dec; 39(49):9689-9701. PubMed ID: 31676603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination.
    Harel T; Quek DQY; Wong BH; Cazenave-Gassiot A; Wenk MR; Fan H; Berger I; Shmueli D; Shaag A; Silver DL; Elpeleg O; Edvardson S
    Neurogenetics; 2018 Dec; 19(4):227-235. PubMed ID: 30043326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mfsd2a-mediated lysolipid transport is important for renal recovery after acute kidney injury.
    Loke RYJ; Chin CF; Liang G; Wong BH; Galam DLA; Tan BC; Chua GL; Minegishi S; Morisawa N; Sidorov I; Heijs B; Titze J; Wenk MR; Torta F; Silver DL
    J Lipid Res; 2023 Aug; 64(8):100416. PubMed ID: 37467896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the lysophospholipid brain uptake mechanism and its inhibition by syncytin-2.
    Martinez-Molledo M; Nji E; Reyes N
    Nat Struct Mol Biol; 2022 Jun; 29(6):604-612. PubMed ID: 35710838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A.
    Wood CAP; Zhang J; Aydin D; Xu Y; Andreone BJ; Langen UH; Dror RO; Gu C; Feng L
    Nature; 2021 Aug; 596(7872):444-448. PubMed ID: 34349262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency in the omega-3 lysolipid transporter Mfsd2a leads to aberrant oligodendrocyte lineage development and hypomyelination.
    Sengottuvel V; Hota M; Oh J; Galam DL; Wong BH; Wenk MR; Ghosh S; Torta F; Silver DL
    J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37104036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.